IRIS

ZUCALI, PAOLO ANDREA

ZUCALI, PAOLO ANDREA  

Dipartimento Scienze Biomediche  

Mostra records
Risultati 1 - 20 di 236 (tempo di esecuzione: 0.022 secondi).
Titolo Data di pubblicazione Autore(i) File
"One marker does not fit all": additional translational and validation studies are needed to identify faithful predictors of pemetrexed activity in mesothelioma 1-gen-2013 Giovannetti, Elisa; Peters, Godefridus J; Zucali, Paolo A
2-¹⁸fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) for postchemotherapy seminoma residual lesions: a retrospective validation of the SEMPET trial 1-gen-2012 Bachner, M; Loriot, Y; Gross-Goupil, M; Zucali, P A; Horwich, A; Germa-Lluch, J-R; Kollmannsberger, C; Stoiber, F; Fléchon, A; Oechsle, K; Gillessen, S; Oldenburg, J; Cohn-Cedermark, G; Daugaard, G; Morelli, F; Sella, A; Harland, S; Kerst, M; Gampe, J; Dittrich, C; Fizazi, K; De Santis, M
721P Ipilimumab and nivolumab compassionate use program in metastatic renal cell carcinoma patients with intermediate or poor IMDC risk score: The large multicenter Italian study 1-gen-2020 Basso, U.; Paolieri, F.; Porta, C. G.; De Giorgi, U.; Bracarda, S.; Antonuzzo, L.; Atzori, F.; Cartenì, G.; Procopio, G.; Fratino, L.; D'Arcangelo, M.; Fornarini, G.; Zucali, P. A.; Cusmai, A.; Santoni, M.; Baldessari, C.; Naglieri, E.; Panni, S.; Zagonel, V.; Tortora, G.
[Combination of 5-Fluorouracil and folinic acid--is it still the standard therapy for advanced colorectal carcinoma?] 1-gen-2000 Carnaghi, C; Zucali, P; Garassino, I
A phase 1 dose-escalation study of the oral histone deacetylase inhibitor abexinostat in combination with standard hypofractionated radiotherapy in advanced solid tumors 1-gen-2017 Deutsch, Eric; Moyal, Elizabeth Cohen-Jonathan; Gregorc, Vanesa; Zucali, Paolo Andrea; Menard, Jean; Soria, Jean-Charles; Kloos, Ioana; Hsu, Jeff; Luan, Ying; Liu, Emily; Vezan, Remus; Graef, Thorsten; Rivera, Sofia
A phase II study of the combination of gemcitabine and imatinib mesylate in pemetrexed-pretreated patients with malignant pleural mesothelioma 1-gen-2020 Zucali, Pa; Perrino, M; de Vincenzo, F; Giordano, L; Cordua, N; D’Antonio, F; Santoro, A
A Phase-1b study of tivantinib (ARQ 197) in adult patients with hepatocellular carcinoma and cirrhosis 1-gen-2013 Santoro, A; Simonelli, M; Rodriguez-Lope, C; Zucali, P; Camacho, Lh; Granito, A; Senzer, N; Rimassa, L; Abbadessa, G; Schwartz, B; Lamar, M; Savage, Re; Bruix, J
A red blood cell-based score in the prognostication of patients with metastatic RCC of the Meet-URO 15 study 1-gen-2024 Anpalakhan, Shobana; Banna, Giuseppe Luigi; Rebuzzi, Sara Elena; Fornarini, Giuseppe; Maruzzo, Marco; Zucali, Paolo Andrea; Catalano, Fabio; Antonj, Ludovica; Tudini, Marianna; Fratino, Lucia; Malgeri, Andrea; Rescigno, Pasquale; Signori, Alessio; Acunzo, Alessandro; Silini, Enrico Maria; Mazzaschi, Giulia; Buti, Sebastiano
A specific inhibitor of lactate dehydrogenase overcame the resistance toward gemcitabine in hypoxic mesothelioma cells, and modulated the expression of the human equilibrative transporter-1 1-gen-2016 Giovannetti, Elisa; Leon, Leticia G; Gómez, Valentina E; Zucali, Paolo A; Minutolo, Filippo; Peters, Godefridus J
A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors 1-gen-2014 Petrini, Iacopo; Meltzer, Paul S; Kim, In-Kyu; Lucchi, Marco; Park, Kang-Seo; Fontanini, Gabriella; Gao, James; Zucali, Paolo A; Calabrese, Fiorella; Favaretto, Adolfo; Rea, Federico; Rodriguez-Canales, Jaime; Walker, Robert L; Pineda, Marbin; Zhu, Yuelin J; Lau, Christopher; Killian, Keith J; Bilke, Sven; Voeller, Donna; Dakshanamurthy, Sivanesan; Wang, Yisong; Giaccone, Giuseppe
Achieving Consensus for Management of Hormone-Sensitive, Low-Volume Metastatic Prostate Cancer in Italy 1-gen-2022 Verzoni, Elena; Pappagallo, Giovanni; Alongi, Filippo; Arcangeli, Stefano; Francolini, Giulio; Galanti, Daniele; Galli, Luca; Maruzzo, Marco; Rossetti, Sabrina; Siepe, Giambattista; Triggiani, Luca; Zucali, Paolo Andrea; D'Angelillo, Rolando Maria
Activity and safety of trabectedin in patients with sarcomatoid / biphasic malignant pleural mesothelioma (MPM) 1-gen-2015 Cortinovis, Dl; Hollander, Lh; Floriani, Ic; Grosso, F; Marinello, A; Ceresoli, Gl; Pacchetti, I; Zucali, Pa; D'Incalci, M; Canova, S; Abbate, Mi; Ugo, F; Vukcaj, S; Bidoli, P
Activity of a specific inhibitor, gefitinib (Iressa, ZD1839), of epidermal growth factor receptor in refractory non-small-cell lung cancer 1-gen-2004 Santoro, A.; Cavina, R.; Latteri, F.; Zucali, P. A.; Ginanni, V.; Campagnoli, E.; Ferrari, B.; Morenghi, E.; Pedicini, V.; Roncalli, M.; Alloisio, M.; Ravasi, G.; Soto Parra, H. J.
Addition of temozolomide to radiotherapy for treatment of newly diagnosed anaplastic gliomas 1-gen-2009 Simonelli, M; Banna, G; Navarria, P; Di Ieva, A; Zucali, P; De Vincenzo, F; Gaetani, P; Condorelli, R; Baena, Rry; Scorsetti, M; Santoro, A
Advances in drug treatments for mesothelioma 1-gen-2022 Zucali, Paolo Andrea; De Vincenzo, Fabio; Perrino, Matteo; Digiacomo, Nunzio; Cordua, Nadia; D'Antonio, Federica; Borea, Federica; Fazio, Roberta; Pirozzi, Angelo; Santoro, Armando
Advances in the biology of malignant pleural mesothelioma 1-gen-2011 Zucali, Pa; Ceresoli, Gl; De Vincenzo, F; Simonelli, M; Lorenzi, E; Gianoncelli, L; Santoro, A
Advancing Prostate Cancer Care: Prostate-specific Membrane Antigen–based Radioligand Therapy at the Forefront 1-gen-2024 Evangelista, Laura; Cecchi, Luigi; Zucali, Paolo Andrea
An Italian survey on the use of denosumab for the management of skeletal-related events in patients with bone metastases 1-gen-2022 Berardi, R; Berruti, A; Brogelli, L; Zucali, P A
Analysis of epidermal growth factor receptor expression as a predictive factor for response to gefitinib ('Iressa', ZD1839) in non-small-cell lung cancer 1-gen-2004 Parra, Hs; Cavina, R; Latteri, F; Zucali, Pa; Campagnoli, E; Morenghi, E; Grimaldi, Gc; Roncalli, M; Santoro, A
Anti-angiogenic therapies for malignant pleural mesothelioma 1-gen-2012 Ceresoli, Giovanni Luca; Zucali, Paolo Andrea